Regulatory Network in Protein Phosphorylation
[Home] [About] [Browse Kinome] [Phosphorylation Prediction] [Expression Analysis] [Statistics] [Help] Version 1.0

[Back to Kinase PKCi]
Substrate: VIM

Description: Vimentin.

Ensembl ID: ENSG00000026025

UniprotKB/SwissProt: VIME_HUMAN (P08670)

Function: Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells.

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization:
Protein Domain and Phosphorylation Sites:

The phosphorylated sites of VIM

No.SubstrateUniProtKB IDPositionPhosphoPeptideSolvent AccessibilityCatalytic kinaseSourceComputational Annotation of Catalytic KinaseInteracting PartnersExpression Analysis
1VIMVIME_HUMANS5-MSTR S VSSSS 26.83% Swiss-Prot 55.0 View   
2VIMVIME_HUMANS7STRSV S SSSYR 26.25%PKC_group Swiss-Prot 55.0  ViewAnalyzing
3VIMVIME_HUMANS7STRSV S SSSYR 26.25%PKCa HPRD:01899(in vitro)  ViewAnalyzing
4VIMVIME_HUMANS7STRSV S SSSYR 26.25%PKA_group Swiss-Prot 55.0  ViewAnalyzing
5VIMVIME_HUMANS7STRSV S SSSYR 26.25%PKACa HPRD:01899(in vitro)  ViewAnalyzing
6VIMVIME_HUMANS8TRSVS S SSYRR 22.58% Swiss-Prot 55.0 View   
7VIMVIME_HUMANS9RSVSS S SYRRM 24.71%PKC_group Swiss-Prot 55.0  ViewAnalyzing
8VIMVIME_HUMANS9RSVSS S SYRRM 24.71%PKCa HPRD:01899(in vitro)  ViewAnalyzing
9VIMVIME_HUMANS10SVSSS S YRRMF 25.30%PKC_group Swiss-Prot 55.0  ViewAnalyzing
10VIMVIME_HUMANS10SVSSS S YRRMF 25.30%PKCa HPRD:01899(in vitro)  ViewAnalyzing
11VIMVIME_HUMANS25TASRP S SSRSY 39.57%PKA_group Swiss-Prot 55.0 (Similarity) ViewAnalyzing
12VIMVIME_HUMANS25TASRP S SSRSY 39.57%PKACa HPRD:01899(in vitro)  ViewAnalyzing
13VIMVIME_HUMANS25TASRP S SSRSY 39.57%PKC_group Swiss-Prot 55.0 (Similarity) ViewAnalyzing
14VIMVIME_HUMANS25TASRP S SSRSY 39.57%PKCa HPRD:01899(in vitro)  ViewAnalyzing
15VIMVIME_HUMANS26ASRPS S SRSYV 32.24%PAK2 HPRD:01899(in vitro)  ViewAnalyzing
16VIMVIME_HUMANS26ASRPS S SRSYV 32.24%PKCa HPRD:01899(in vitro)  ViewAnalyzing
17VIMVIME_HUMANS26ASRPS S SRSYV 32.24%PAK_group Phospho.ELM 7.0 ViewAnalyzing
18VIMVIME_HUMANS26ASRPS S SRSYV 32.24%PKC_group Swiss-Prot 55.0 (Similarity) ViewAnalyzing
19VIMVIME_HUMANS27SRPSS S RSYVT 29.59% Swiss-Prot 55.0 View   
20VIMVIME_HUMANS27SRPSS S RSYVT 29.59% Phospho.ELM 7.0View   
21VIMVIME_HUMANS34SYVTT S TRTYS 13.41%PKCa HPRD:01899(in vitro)  ViewAnalyzing
22VIMVIME_HUMANS34SYVTT S TRTYS 13.41%PKC_group Swiss-Prot 55.0 (Similarity) ViewAnalyzing
23VIMVIME_HUMANS39STRTY S LGSAL 26.16%PKCa HPRD:01899(in vitro)  ViewAnalyzing
24VIMVIME_HUMANS39STRTY S LGSAL 26.16%CaMK2_group Swiss-Prot 55.0  ViewAnalyzing
25VIMVIME_HUMANS39STRTY S LGSAL 26.16%PAK_group Phospho.ELM 7.0 ViewAnalyzing
26VIMVIME_HUMANS39STRTY S LGSAL 26.16%PKA_group Swiss-Prot 55.0  ViewAnalyzing
27VIMVIME_HUMANS39STRTY S LGSAL 26.16%PAK2 HPRD:01899(in vitro)  ViewAnalyzing
28VIMVIME_HUMANS39STRTY S LGSAL 26.16%PKC_group Swiss-Prot 55.0  ViewAnalyzing
29VIMVIME_HUMANS39STRTY S LGSAL 26.16%MAPKAPK2 Phospho.ELM 7.0  ViewAnalyzing
30VIMVIME_HUMANS39STRTY S LGSAL 26.16%PKACa HPRD:01899(in vitro)  ViewAnalyzing
31VIMVIME_HUMANS42TYSLG S ALRPS 29.44%PKCa HPRD:01899(in vitro)  ViewAnalyzing
32VIMVIME_HUMANS42TYSLG S ALRPS 29.44%PKC_group Swiss-Prot 55.0  ViewAnalyzing
33VIMVIME_HUMANS47SALRP S TSRSL 32.36% Swiss-Prot 55.0 View   
34VIMVIME_HUMANS47SALRP S TSRSL 32.36%PKACa HPRD:01899(in vitro)  ViewAnalyzing
35VIMVIME_HUMANS51PSTSR S LYASS 26.04%MAPKAPK2 Phospho.ELM 7.0  ViewAnalyzing
36VIMVIME_HUMANS51PSTSR S LYASS 26.04%PAK2 HPRD:01899(in vitro)  ViewAnalyzing
37VIMVIME_HUMANS51PSTSR S LYASS 26.04%PAK1 Phospho.ELM 7.0  ViewAnalyzing
38VIMVIME_HUMANS51PSTSR S LYASS 26.04%PKA_group Swiss-Prot 55.0 (Similarity) ViewAnalyzing
39VIMVIME_HUMANS51PSTSR S LYASS 26.04%PKC_group Swiss-Prot 55.0 (Similarity) ViewAnalyzing
40VIMVIME_HUMANS51PSTSR S LYASS 26.04%PAK_group Phospho.ELM 7.0 ViewAnalyzing
41VIMVIME_HUMANY53TSRSL Y ASSPG 12.99% Phospho.ELM 7.0View   
42VIMVIME_HUMANY53TSRSL Y ASSPG 12.99% Swiss-Prot 55.0 (Similarity)View   
43VIMVIME_HUMANS55RSLYA S SPGGV 24.41% Swiss-Prot 55.0 View   
44VIMVIME_HUMANS56SLYAS S PGGVY 21.28% Swiss-Prot 55.0 View   
45VIMVIME_HUMANS56SLYAS S PGGVY 21.28%CDC2 HPRD:01899(in vitro;in vivo)  ViewAnalyzing
46VIMVIME_HUMANS56SLYAS S PGGVY 21.28%CDC2(CDK1) Phospho.ELM 7.0 ViewAnalyzing
47VIMVIME_HUMANS56SLYAS S PGGVY 21.28%PAK1 Phospho.ELM 7.0  ViewAnalyzing
48VIMVIME_HUMANS56SLYAS S PGGVY 21.28%MAPKAPK2 Phospho.ELM 7.0  ViewAnalyzing
49VIMVIME_HUMANY61SPGGV Y ATRSS 12.91% Swiss-Prot 55.0 View   
50VIMVIME_HUMANY61SPGGV Y ATRSS 12.91% Phospho.ELM 7.0View   
51VIMVIME_HUMANS66YATRS S AVRLR 27.74%PAK_group Phospho.ELM 7.0 ViewAnalyzing
52VIMVIME_HUMANS66YATRS S AVRLR 27.74%PKA_group Swiss-Prot 55.0 (Similarity) ViewAnalyzing
53VIMVIME_HUMANS66YATRS S AVRLR 27.74%PKC_group Swiss-Prot 55.0 (Similarity) ViewAnalyzing
54VIMVIME_HUMANS66YATRS S AVRLR 27.74%PAK2 HPRD:01899(in vitro)  ViewAnalyzing
55VIMVIME_HUMANS72AVRLR S SVPGV 40.03% Swiss-Prot 55.0 View   
56VIMVIME_HUMANS72AVRLR S SVPGV 40.03%ROCK1 HPRD:01899(in vitro;in vivo)  ViewAnalyzing
57VIMVIME_HUMANS72AVRLR S SVPGV 40.03%ROCK1 Phospho.ELM 7.0  ViewAnalyzing
58VIMVIME_HUMANS72AVRLR S SVPGV 40.03%ROCK_group Phospho.ELM 7.0 ViewAnalyzing
59VIMVIME_HUMANS73VRLRS S VPGVR 26.37%PAK2 HPRD:01899(in vitro)  ViewAnalyzing
60VIMVIME_HUMANS73VRLRS S VPGVR 26.37%AurB(Aurora B) Phospho.ELM 7.0 ViewAnalyzing
61VIMVIME_HUMANS73VRLRS S VPGVR 26.37%PAK1 Phospho.ELM 7.0  ViewAnalyzing
62VIMVIME_HUMANS73VRLRS S VPGVR 26.37%PAK_group Phospho.ELM 7.0 ViewAnalyzing
63VIMVIME_HUMANS73VRLRS S VPGVR 26.37%ROCK_group Phospho.ELM 7.0 ViewAnalyzing
64VIMVIME_HUMANS73VRLRS S VPGVR 26.37% Swiss-Prot 55.0 View   
65VIMVIME_HUMANS83RLLQD S VDFSL 15.60%CaMK2_group Swiss-Prot 55.0 (Similarity) ViewAnalyzing
66VIMVIME_HUMANS83RLLQD S VDFSL 15.60%CaMK2a Phospho.ELM 7.0  ViewAnalyzing
67VIMVIME_HUMANS83RLLQD S VDFSL 15.60%CaMK2d HPRD:01899(in vitro)  ViewAnalyzing
68VIMVIME_HUMANS83RLLQD S VDFSL 15.60%MAPKAPK2 Phospho.ELM 7.0  ViewAnalyzing
69VIMVIME_HUMANY117DRFAN Y IDKVR 13.68% Swiss-Prot 55.0 View   
70VIMVIME_HUMANS214DVDNA S LARLD 28.90% Swiss-Prot 55.0 View   
71VIMVIME_HUMANS214DVDNA S LARLD 28.90% Phospho.ELM 7.0View   
72VIMVIME_HUMANS412EESRI S LPLPN 23.87% Phospho.ELM 7.0View   
73VIMVIME_HUMANS412EESRI S LPLPN 23.87% Swiss-Prot 55.0 View   
74VIMVIME_HUMANS420LPNFS S LNLRE 19.69% Swiss-Prot 55.0 View   
75VIMVIME_HUMANT426LNLRE T NLDSL 34.35% Phospho.ELM 7.0View   
76VIMVIME_HUMANS430ETNLD S LPLVD 34.74% Swiss-Prot 55.0 View   
77VIMVIME_HUMANS430ETNLD S LPLVD 34.74% Phospho.ELM 7.0View   
78VIMVIME_HUMANT446TLLIK T VETRD 19.31% Swiss-Prot 55.0 View   
79VIMVIME_HUMANT458QVINE T SQHHD 29.24% Swiss-Prot 55.0 View   
80VIMVIME_HUMANS459VINET S QHHDD 22.72% Swiss-Prot 55.0 View   
81VIMVIME_HUMANS459VINET S QHHDD 22.72% Phospho.ELM 7.0View